The Board of Directors of CanSino Biologics Inc. has authorized a buyback plan on January 23, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
20.35 HKD | -3.78% | -10.35% | -13.59% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-13.59% | 1.14B | |
-2.29% | 89.38B | |
-3.95% | 37.92B | |
-13.07% | 32.04B | |
+63.05% | 26.03B | |
-22.14% | 14.14B | |
-7.96% | 12.88B | |
-9.33% | 11.77B | |
-46.33% | 10.85B | |
+5.77% | 8.92B |
- Stock Market
- Equities
- 6185 Stock
- News CanSino Biologics Inc.
- CanSino Biologics Inc. authorizes a Buyback Plan.